PURE Bioscience Q1 revenue rises 54% to $718K; net loss narrows to $735K

PURE BIOSCIENCE, INC.

2024-Q1 EPS reported -$0.01 revenue$718,000

Net product sales of $718K for Q1 FY2024, up $251K from $467K in Q1 FY2023.
Net loss improved to $735K from $993K year-over-year; EPS unchanged at ($0.01).
Excluding share-based compensation, net loss was $655K vs $909K.
CEO cites sales initiatives paying off; VP of Sales highlights competitive advantage in food safety.
Business update stresses customer focus, IoT/SaaS innovation, and 100 years of combined staff experience.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.